Brendan Teehan
Chief Operating Officer at ACADIA PHARMACEUTICALS INC.
Net worth: 687 189 $ as of 2024-04-29
Profile
Brendan P.
Teehan is currently the Chief Operating Officer, EVP & Head-Commercial at ACADIA Pharmaceuticals, Inc. He previously worked as the Vice President-Building & Provider Solutions at Tesaro, Inc. from 2016 to 2018, and as the Senior Vice President & Vice President at RT Oncology Services Corp.
from 2012 to 2016.
Mr. Teehan holds an MBA degree from Carnegie Mellon University and an undergraduate degree from the University of Notre Dame, which he received in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-01 | 42,133 ( 0.03% ) | 687 189 $ | 2024-04-29 |
Brendan Teehan active positions
| Companies | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Chief Operating Officer | 2021-10-31 |
Former positions of Brendan Teehan
| Companies | Position | End |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 2018-06-30 |
RT Oncology Services Corp.
 RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2016-03-31 |
Training of Brendan Teehan
| University of Notre Dame | Undergraduate Degree |
| Carnegie Mellon University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
RT Oncology Services Corp.
RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Brendan Teehan
